RadNet Artificial Intelligence Subsidiaries, DeepHealth and Quantib, Obtain FDA Clearance for Mammography and Prostate AI Tools
May 16, 2022 06:00 ET
|
RadNet, Inc.
CAMBRIDGE, Mass. and ROTTERDAM, The Netherlands and LOS ANGELES, May 16, 2022 (GLOBE NEWSWIRE) -- RadNet, Inc., (NASDAQ: RDNT) today announced that it has received FDA clearances for its DeepHealth...
RadNet To Participate in the White House Cancer Moonshot Goals Forum
May 11, 2022 06:00 ET
|
RadNet, Inc.
LOS ANGELES, May 11, 2022 (GLOBE NEWSWIRE) -- RadNet, Inc. (NASDAQ: RDNT), today announced that Howard Berger, M.D., the company’s President and Chief Executive Officer, will participate this week...
RadNet Reports First Quarter Financial Results with Record Revenue and Adjusted EBITDA(1) from Imaging Center Operations and Revises Upwards 2022 Financial Guidance Ranges
May 09, 2022 06:00 ET
|
RadNet, Inc.
Revenue increased 8.4% to $341.8 million in the first quarter of 2022 from $315.3 million in the first quarter of 2021; Excluding Revenue from our Artificial Intelligence (“AI”) reporting segment,...
RadNet, Inc. to Present at the Bank of America Securities 2022 Healthcare Conference on May 11th, 2022
May 06, 2022 19:05 ET
|
RadNet, Inc.
LOS ANGELES, May 06, 2022 (GLOBE NEWSWIRE) -- RadNet, Inc. (NASDAQ: RDNT), a national leader in providing high-quality, cost-effective diagnostic imaging services through a network of fully-owned...
RadNet, Inc. Announces the Date of its First Quarter 2022 Financial Results Conference Call
April 27, 2022 06:00 ET
|
RadNet, Inc.
LOS ANGELES, April 27, 2022 (GLOBE NEWSWIRE) -- RadNet, Inc. (NASDAQ: RDNT), a national leader in providing high-quality, cost-effective diagnostic imaging services through a network of owned and...
RadNet, Inc. to Present at the Sidoti & Company Spring 2022 Virtual Investor Conference on Thursday, March 24th
March 22, 2022 06:00 ET
|
RadNet, Inc.
LOS ANGELES, March 22, 2022 (GLOBE NEWSWIRE) -- RadNet, Inc. (NASDAQ: RDNT), a national leader in providing high-quality, cost-effective diagnostic imaging services through a network of fully-owned...
RadNet Reports Fourth Quarter 2021 Results and Releases 2022 Financial Guidance
March 01, 2022 06:00 ET
|
RadNet, Inc.
Revenue increased 8.0% to $333.2 million in the fourth quarter of 2021 from $308.5 million in the fourth quarter of 2020Adjusted EBITDA(1) increased 7.5% to $54.5 million in the fourth quarter of 2021...
RadNet, Inc. Announces Date of its Fourth Quarter 2021 Financial Results Conference Call
February 23, 2022 06:00 ET
|
RadNet, Inc.
LOS ANGELES, Feb. 23, 2022 (GLOBE NEWSWIRE) -- RadNet, Inc. (NASDAQ: RDNT), a national leader in providing high-quality, cost-effective diagnostic imaging services through a network of owned and...
RadNet Completes the acquisitions of Aidence Holding B.V. and Quantib B.V. to Address Opportunities in Lung and Prostate Cancer Diagnosis and Screening with Artificial Intelligence
January 24, 2022 06:00 ET
|
RadNet, Inc.
When combined with RadNet’s existing DeepHealth mammography AI division, the two acquisitions provide RadNet with the basis for future offerings for widespread cancer screening programs for the three...
RadNet, Inc. to Present at the Jefferies London Healthcare Conference
November 15, 2021 06:00 ET
|
RadNet, Inc.
LOS ANGELES, Nov. 15, 2021 (GLOBE NEWSWIRE) -- RadNet, Inc. (NASDAQ: RDNT), a national leader in providing high-quality, cost-effective diagnostic imaging services through a network of fully-owned...